Insider Trading & Ownership of Ali Behbahani

Location
Menlo Park, CA
Summary
The estimated net worth of Ali Behbahani is at least $229,912,335 dollars as of 20 Mar 2026. Ali Behbahani is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $108.9M. Ali Behbahani is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.64M. Ali Behbahani is the Director, 10%+ Owner of SpyGlass Pharma, Inc. and owns shares of SpyGlass Pharma, Inc. (SGP) stock worth about $37.77M. Ali Behbahani is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $16.81M. Ali Behbahani is the Director, 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $15.26M. Ali Behbahani is the Director of Black Diamond Therapeutics, Inc. and owns shares of Black Diamond Therapeutics, Inc. (BDTX) stock worth about $10.86M. Ali Behbahani is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Ali Behbahani is the Director of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $303.6K. Ali Behbahani is the Director of CVRx, Inc. and owns shares of CVRx, Inc. (CVRX) stock worth about $146K. Ali Behbahani is the Director of MINERVA SURGICAL INC and owns shares of MINERVA SURGICAL INC (UTRS) stock worth about $11.9K. Ali Behbahani is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $3.8K.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Ali Behbahani and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Ali Behbahani has 19 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $229,912,335.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Savara Inc ($108,897,125).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Ali Behbahani

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SVRA Savara Inc 10%+ Owner $108,897,125 17 Jul 2023
MBX MBX Biosciences, Inc. 10%+ Owner $38,638,855 16 Sep 2024
SGP SpyGlass Pharma, Inc. Director, 10%+ Owner $37,772,629 09 Feb 2026
TRVI Trevi Therapeutics, Inc. 10%+ Owner $16,814,393 31 Dec 2025
KRRO Korro Bio, Inc. Director, 10%+ Owner $15,263,221 10 Mar 2026
BDTX Black Diamond Therapeutics, Inc. Director $10,856,156 20 Mar 2026
MTCR Metacrine, Inc. 10%+ Owner $1,204,731 10 Dec 2021
ACLX Arcellx, Inc. Director $303,561 12 Aug 2025
CVRX CVRx, Inc. Director $145,955 04 Jun 2024
UTRS MINERVA SURGICAL INC Director $11,924 10 Jun 2022
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $3,785 13 Jun 2023
ADAP Adaptimmune Therapeutics PLC Director $0 15 Aug 2025
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$26,426 -100% 02 Oct 2025
AKUS Akouos, Inc. 10%+ Owner 30 Nov 2022
CRSP CRISPR Therapeutics AG Director 05 Jun 2025
GNCA GENOCEA BIOSCIENCES, INC. Director, 10%+ Owner 24 May 2022
GLUE Monte Rosa Therapeutics, Inc. Director, 10%+ Owner 13 Jun 2025
NKTX Nkarta, Inc. Director 05 Jun 2025
OYST Oyster Point Pharma, Inc. Director 03 Jan 2023

Insider Transactions Reported by Ali Behbahani:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored